How much is the Transdermal Drug Delivery Market market?

The transdermal drug delivery market market size is estimated to grow at $$ 2.44 bn in 2023. Read More

What is the growth rate of the Transdermal Drug Delivery Market market?

The growth rate of the transdermal drug delivery market year-over-year is 4.9%. Read More

Which region held the largest market share in the Transdermal Drug Delivery Market market?

North America is the region to held the largest market share with 55% growth. Read More

Who are the key players in the Transdermal Drug Delivery Market market?

3M Co., Boehringer Ingelheim International GmbH, Croda International Plc, Hisamitsu Pharmaceutical Co. Inc., Johnson and Johnson, Kindeva Drug Delivery L.P., Luye Pharma Group Ltd., .... Read More

Which Segment has the largest market share in the Transdermal Drug Delivery Market market?

Application is the segment that has the largest market share in the market. Read More

Transdermal Drug Delivery Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, France, UK, Japan - Size and Forecast 2024-2028

Published: Nov 2023
Pages: 168
SKU: IRTNTR76784

Enjoy complimentary customisation on priority with our Enterprise License!

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global transdermal drug delivery market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global transdermal drug delivery market 2018 - 2022 ($ billion)

4.2 Application Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Application Segment 2018 - 2022 ($ billion)

4.3 Type Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – Type Segment 2018 - 2022 ($ billion)

4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)

4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

6.1 Market segments
- Exhibit 30: Chart on Application - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Application - Market share 2023-2028 (%)

6.2 Comparison by Application
- Exhibit 32: Chart on Comparison by Application
- Exhibit 33: Data Table on Comparison by Application

6.3 Analgesics - Market size and forecast 2023-2028
- Exhibit 34: Chart on Analgesics - Market size and forecast 2023-2028 ($ billion)
- Exhibit 35: Data Table on Analgesics - Market size and forecast 2023-2028 ($ billion)
- Exhibit 36: Chart on Analgesics - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Analgesics - Year-over-year growth 2023-2028 (%)

6.4 Neurological disorders - Market size and forecast 2023-2028
- Exhibit 38: Chart on Neurological disorders - Market size and forecast 2023-2028 ($ billion)
- Exhibit 39: Data Table on Neurological disorders - Market size and forecast 2023-2028 ($ billion)
- Exhibit 40: Chart on Neurological disorders - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Neurological disorders - Year-over-year growth 2023-2028 (%)

6.5 Hormone replacement therapy - Market size and forecast 2023-2028
- Exhibit 42: Chart on Hormone replacement therapy - Market size and forecast 2023-2028 ($ billion)
- Exhibit 43: Data Table on Hormone replacement therapy - Market size and forecast 2023-2028 ($ billion)
- Exhibit 44: Chart on Hormone replacement therapy - Year-over-year growth 2023-2028 (%)
- Exhibit 45: Data Table on Hormone replacement therapy - Year-over-year growth 2023-2028 (%)

6.6 Cardiovascular disorders - Market size and forecast 2023-2028
- Exhibit 46: Chart on Cardiovascular disorders - Market size and forecast 2023-2028 ($ billion)
- Exhibit 47: Data Table on Cardiovascular disorders - Market size and forecast 2023-2028 ($ billion)
- Exhibit 48: Chart on Cardiovascular disorders - Year-over-year growth 2023-2028 (%)
- Exhibit 49: Data Table on Cardiovascular disorders - Year-over-year growth 2023-2028 (%)

6.7 Others - Market size and forecast 2023-2028
- Exhibit 50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
- Exhibit 51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
- Exhibit 52: Chart on Others - Year-over-year growth 2023-2028 (%)
- Exhibit 53: Data Table on Others - Year-over-year growth 2023-2028 (%)

6.8 Market opportunity by Application
- Exhibit 54: Market opportunity by Application ($ billion)
- Exhibit 55: Data Table on Market opportunity by Application ($ billion)

7 Market Segmentation by Type

7.1 Market segments
- Exhibit 56: Chart on Type - Market share 2023-2028 (%)
- Exhibit 57: Data Table on Type - Market share 2023-2028 (%)

7.2 Comparison by Type
- Exhibit 58: Chart on Comparison by Type
- Exhibit 59: Data Table on Comparison by Type

7.3 Transdermal patches - Market size and forecast 2023-2028
- Exhibit 60: Chart on Transdermal patches - Market size and forecast 2023-2028 ($ billion)
- Exhibit 61: Data Table on Transdermal patches - Market size and forecast 2023-2028 ($ billion)
- Exhibit 62: Chart on Transdermal patches - Year-over-year growth 2023-2028 (%)
- Exhibit 63: Data Table on Transdermal patches - Year-over-year growth 2023-2028 (%)

7.4 Transdermal semisolids - Market size and forecast 2023-2028
- Exhibit 64: Chart on Transdermal semisolids - Market size and forecast 2023-2028 ($ billion)
- Exhibit 65: Data Table on Transdermal semisolids - Market size and forecast 2023-2028 ($ billion)
- Exhibit 66: Chart on Transdermal semisolids - Year-over-year growth 2023-2028 (%)
- Exhibit 67: Data Table on Transdermal semisolids - Year-over-year growth 2023-2028 (%)

7.5 Market opportunity by Type
- Exhibit 68: Market opportunity by Type ($ billion)
- Exhibit 69: Data Table on Market opportunity by Type ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 71: Chart on Market share by geography 2023-2028 (%)
- Exhibit 72: Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Exhibit 73: Chart on Geographic comparison
- Exhibit 74: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 Germany - Market size and forecast 2023-2028
- Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.9 Japan - Market size and forecast 2023-2028
- Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
- Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
- Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)

9.10 France - Market size and forecast 2023-2028
- Exhibit 103: Chart on France - Market size and forecast 2023-2028 ($ billion)
- Exhibit 104: Data Table on France - Market size and forecast 2023-2028 ($ billion)
- Exhibit 105: Chart on France - Year-over-year growth 2023-2028 (%)
- Exhibit 106: Data Table on France - Year-over-year growth 2023-2028 (%)

9.11 UK - Market size and forecast 2023-2028
- Exhibit 107: Chart on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 108: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 109: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 110: Data Table on UK - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Exhibit 111: Market opportunity by geography ($ billion)
- Exhibit 112: Data Tables on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 113: Impact of drivers and challenges in 2023 and 2028

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 114: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 115: Overview on factors of disruption

11.4 Industry risks
- Exhibit 116: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 117: Vendors covered

12.2 Market positioning of vendors
- Exhibit 118: Matrix on vendor position and classification

12.3 3M Co.
- Exhibit 119: 3M Co. - Overview
- Exhibit 120: 3M Co. - Business segments
- Exhibit 121: 3M Co. - Key news
- Exhibit 122: 3M Co. - Key offerings
- Exhibit 123: 3M Co. - Segment focus

12.4 Boehringer Ingelheim International GmbH
- Exhibit 124: Boehringer Ingelheim International GmbH - Overview
- Exhibit 125: Boehringer Ingelheim International GmbH - Business segments
- Exhibit 126: Boehringer Ingelheim International GmbH - Key news
- Exhibit 127: Boehringer Ingelheim International GmbH - Key offerings
- Exhibit 128: Boehringer Ingelheim International GmbH - Segment focus

12.5 Croda International Plc
- Exhibit 129: Croda International Plc - Overview
- Exhibit 130: Croda International Plc - Business segments
- Exhibit 131: Croda International Plc - Key news
- Exhibit 132: Croda International Plc - Key offerings
- Exhibit 133: Croda International Plc - Segment focus

12.6 Hisamitsu Pharmaceutical Co. Inc.
- Exhibit 134: Hisamitsu Pharmaceutical Co. Inc. - Overview
- Exhibit 135: Hisamitsu Pharmaceutical Co. Inc. - Product / Service
- Exhibit 136: Hisamitsu Pharmaceutical Co. Inc. - Key offerings

12.7 Johnson and Johnson
- Exhibit 137: Johnson and Johnson - Overview
- Exhibit 138: Johnson and Johnson - Business segments
- Exhibit 139: Johnson and Johnson - Key news
- Exhibit 140: Johnson and Johnson - Key offerings
- Exhibit 141: Johnson and Johnson - Segment focus

12.8 Kindeva Drug Delivery L.P.
- Exhibit 142: Kindeva Drug Delivery L.P. - Overview
- Exhibit 143: Kindeva Drug Delivery L.P. - Product / Service
- Exhibit 144: Kindeva Drug Delivery L.P. - Key news
- Exhibit 145: Kindeva Drug Delivery L.P. - Key offerings

12.9 Luye Pharma Group Ltd.
- Exhibit 146: Luye Pharma Group Ltd. - Overview
- Exhibit 147: Luye Pharma Group Ltd. - Business segments
- Exhibit 148: Luye Pharma Group Ltd. - Key offerings
- Exhibit 149: Luye Pharma Group Ltd. - Segment focus

12.10 Medherant Ltd.
- Exhibit 150: Medherant Ltd. - Overview
- Exhibit 151: Medherant Ltd. - Product / Service
- Exhibit 152: Medherant Ltd. - Key offerings

12.11 Novartis AG
- Exhibit 153: Novartis AG - Overview
- Exhibit 154: Novartis AG - Business segments
- Exhibit 155: Novartis AG - Key offerings
- Exhibit 156: Novartis AG - Segment focus

12.12 ProSolus Inc.
- Exhibit 157: ProSolus Inc. - Overview
- Exhibit 158: ProSolus Inc. - Product / Service
- Exhibit 159: ProSolus Inc. - Key offerings

12.13 Purdue Pharma LP
- Exhibit 160: Purdue Pharma LP - Overview
- Exhibit 161: Purdue Pharma LP - Product / Service
- Exhibit 162: Purdue Pharma LP - Key offerings

12.14 Radius Health Inc.
- Exhibit 163: Radius Health Inc. - Overview
- Exhibit 164: Radius Health Inc. - Product / Service
- Exhibit 165: Radius Health Inc. - Key offerings

12.15 Teikoku Seiyaku Co. Ltd.
- Exhibit 166: Teikoku Seiyaku Co. Ltd. - Overview
- Exhibit 167: Teikoku Seiyaku Co. Ltd. - Product / Service
- Exhibit 168: Teikoku Seiyaku Co. Ltd. - Key offerings

12.16 UCB SA
- Exhibit 169: UCB SA - Overview
- Exhibit 170: UCB SA - Product / Service
- Exhibit 171: UCB SA - Key offerings

12.17 Viatris Inc.
- Exhibit 172: Viatris Inc. - Overview
- Exhibit 173: Viatris Inc. - Business segments
- Exhibit 174: Viatris Inc. - Key news
- Exhibit 175: Viatris Inc. - Key offerings
- Exhibit 176: Viatris Inc. - Segment focus

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 177: Inclusions checklist
- Exhibit 178: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 179: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 180: Research methodology
- Exhibit 181: Validation techniques employed for market sizing
- Exhibit 182: Information sources

13.5 List of abbreviations
- Exhibit 183: List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES